Emmanuel O Akala
Pharmacy in Bowie, MD

License number
Utah 319384-8911
Issued Date
Nov 26, 1997
Expiration Date
May 31, 2001
Category
Pharmacy
Type
Pharmacist Controlled Substance
Address
Address
Bowie, MD

Professional information

Emmanuel Akala Photo 1

Emmanuel Akala - Mitchellville, MD

Work:
Department of Pharmaceutical Sciences
Member of the Advisory Group of the Center
Department of Pharmaceutical Sciences
Professor of Pharmaceutics
Caremark Floater Pharmacist Part-Time
CVS
Association 2013 Caremark Floater Pharmacist Part-Time - Washington, DC
Associate Professor Department
Department of Pharmaceutical
Assistant Professor
National Institutes of Health Fogarty International - Bethesda, MD
Fellow
Pharmaceutics, Obafemi Awolowo University
Lecturer one and then Senior lecturer
DAAD
Fellow
Education:
University of Utah
Research Associate
University of Utah
Ph.D.
University of Utah
Pharmacy Foreign Graduate Examination
University of Muenster
Ph.D.
The University of Manchester
Ph.D. in Pharmaceutics
University of Ife
Ph.D. in Pharmaceutics
University of Ife
B.Pharm. in Pharmacy
National Institutes of Health Fogarty International Center
Ph.D. in USA and Research Associate
Department of Pharmaceutics and Pharmaceutical Chemistry/ Center for Controlled Chemical


Emmanuel Akala Photo 2

Biodegradable Stealth Polymeric Particles Fabricated Using The Macromonomer Approach By Free Radical Dispersion Polymerization

US Patent:
2012012, May 24, 2012
Filed:
Nov 23, 2010
Appl. No.:
12/952843
Inventors:
Emmanuel AKALA - Mitchellville MD, US
Simeon ADESINA - Lanham MD, US
International Classification:
C08G 63/06, C08G 63/08, C08G 63/60, A61K 31/337, A61K 31/704, A61J 3/00, C08G 63/66, A61P 35/00, B82Y 5/00
US Classification:
514 34, 525450, 525437, 528354, 428402, 514449, 264 4, 977773
Abstract:
The present invention is directed to a crosslinked or non-crosslinked polymer particle, wherein the crosslinked polymer particle comprises a copolymer of poly(alklyene glycol-graft-lactate) that is crosslinked by at least one hydrolysable monmer. Another embodiment of the present invention is a polymer particle comprising a crosslinked polymer particle that is a product of starting materials comprising (a) a hydrophilic monomer, (b) a hydrophobic monomer, and (c) a hydrolysable crosslinking agent. Another embodiment of the present invention is a polymer particle comprising, a crosslinked copolymer comprises structures represented by Formulas (I), (II), and (III), where Formulas (I), (II) and (III) are defined in the specification. Yet other embodiments of the present invention include a method of preparing a methacrylate terminated macromonomer, a method of preparing a crosslinking agent, and a method of preparing a therapeutic agent loaded nanosphere by dispersion polymerization.


Emmanuel Akala Photo 3

Stealth Polymeric Particles For Delivery Of Bioactive Or Diagnostic Agents

US Patent:
2012012, May 24, 2012
Filed:
Nov 23, 2010
Appl. No.:
12/952856
Inventors:
Emmanuel AKALA - Mitchellville MD, US
Oluyomi Okunola - Beltsville MD, US
International Classification:
A61K 31/337, A61K 31/135, C08F 8/00, A61K 31/704, C08F 265/06, C08F 8/32
US Classification:
514 34, 5253289, 526319, 525380, 525386, 525376, 428402, 514449, 514657
Abstract:
The present invention is directed to a crosslinked or non-crosslinked polymer particle, wherein the crosslinked polymer particle comprises a copolymer of poly(alklyene glycol-graft-acrylate) that is crosslinked by at least one hydrolysable monomer or crosslinking agent. The present invention is also directed to a polymer particle comprising a crosslinked polymer particle that is a product of starting materials comprising (a) a hydrophilic monomer, (b) a hydrophobic monomer, and (c) a hydrolysable crosslinking agent (the crosslinking agent may be absent in the case of non-crosslinked particles). The present invention is still further directed to a polymer particle comprising a crosslinked copolymer, where the crosslinked copolymer includes structures represented by Formulas (I), (II), and (III), as defined in the specification. Other embodiments of the present invention also include methods of manufacturing polymer particles.